CD163 and neoplasm: Our results confirmed that B4GALNT1 depletion significantly reduced tumor weight (p < 0.05, Fig. 9c and d), and the absence of B4GALNT1 led to a reduction in CD4 + T cells and CD163 + TAMs (Fig. 9e, f and g).